XBiotech
XBIT
66 hedge funds and large institutions have $62.6M invested in XBiotech in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 10 closing their positions.
0.06% more ownership
Funds ownership: 13.6% → 13.66% (+0.06%)
3% less funds holding
Funds holding: 68 → 66 (-2)
17% less capital invested
Capital invested by funds: $75.3M → $62.6M (-$12.7M)
18% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 22
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
66% less call options, than puts
Call options by funds: $491K | Put options by funds: $1.45M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
CAAS Capital Management
New York
|
+$2.55M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$770K |
| 3 |
BlackRock
New York
|
+$374K |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
+$284K |
| 5 |
TNB
Thomasville National Bank
Thomasville,
Georgia
|
+$252K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$1.27M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$498K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$402K |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$398K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$300K |
XBIT Hedge Fund Activity: Q4 2020 in Review
66 of the 5,677 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q4 2020, worth a combined $62.6M — down 17% from $75.3M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of XBIT and 8 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 18 added.
The largest buyer was CAAS Capital Management, opening a new position worth an estimated $2.55M. The largest seller was Russell Investments Group, cutting an estimated $1.27M.
- 66 institutional investors held XBiotech (XBIT) as of Q4 2020, down from 68 in Q3 2020.
- Funds reported $62.6M of XBiotech stock for Q4 2020, down 17% quarter-over-quarter.
- 8 funds opened new XBiotech positions in Q4 2020 and 10 closed out, a net change of -2 holders.
- The largest XBiotech buyer in Q4 2020 was CAAS Capital Management, an estimated $2.55M added.
- The largest XBiotech seller in Q4 2020 was Russell Investments Group, an estimated $1.27M sold.
Based on aggregated 13F filings for Q4 2020.